Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Metastatic HER-2 positive breast cancer


Azar Fanipakdel

Mashhad university of medical sciences, Iran

: J Clin Exp Oncol

Abstract


The patient is a single 36 years old woman that her Chief Compliant is change in Right breast skin. Invasive ductal carcinoma is confirmed by breast biopsy (ER and PR positive, highKi67 and HER2 positive). Staging work up was conducted and plural effusion detected that was malignant also abnormal absorption in manubrium in Bone scan. By starting the chemotherapy, the oncologist faced to abnormality in the contralateral breast cancer. She was operated and received more local treatment, local recurrence and …. Then when was on anti-HER2and Endocrine Therapy brain metastasis were observed in MRI so radiotherapy was chosen. Eventually uncontrolled local recurrence, more than three line of chemotherapy, repeated brain metastasis result in failure in survival. There are some discussions in these patients: • Local treatment for primary in metastatic breast cancer • Radiotherapy in metastatic patients who are high risk for local recurrence • Discordancy in IHC result • Management of Brain Metastasis • Sequencing of systemic treatment • Management of local recurrence on chest wall And even more subjects depend on time and audience concepts. In the nutshell I hope to have an interactive discussion end to wrap up with some take home messages.

Biography


Azar Fanipakdel is a associate professor of radiation oncology Mashhad university of medical sciences, Mashhad, Iran. She has done Three years of residency covering all oncology- related fields includingadult and pediatric oncology, theoretical and practical training onradiation therapy, chemotherapy, hormone therapy, and palliative care. She is member of Executive Committee, International Multidisciplinary Cancer Congress ,Mashhad, Iran.

E-mail: [email protected]

Track Your Manuscript

Media Partners

GET THE APP